Thepleasantoak, Inc - Medicare Mental Health Clinic in Augusta, ME

Thepleasantoak, Inc is a medicare enrolled mental health clinic (Social Worker - Clinical) in Augusta, Maine. The current practice location for Thepleasantoak, Inc is 49 Oak St, Augusta, Maine. For appointments, you can reach them via phone at (207) 441-6624. The mailing address for Thepleasantoak, Inc is 49 Oak St, Augusta, Maine and phone number is (207) 441-6624.

Thepleasantoak, Inc is licensed to practice in Maine (license number LC7597). The clinic also participates in the medicare program and its NPI number is 1275923369. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (207) 441-6624.

Contact Information

Thepleasantoak, Inc
49 Oak St
Augusta
ME 04330-5118
(207) 441-6624
(207) 622-6290

Mental Health Clinic Profile

Full NameThepleasantoak, Inc
SpecialitySocial Worker
Location49 Oak St, Augusta, Maine
Authorized Official Name and PositionSusan A Brochu (LICENSED CLINICAL SOCIAL WORKER)
Authorized Official Contact2074416624
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Thepleasantoak, Inc
49 Oak St
Augusta
ME 04330-5118

Ph: (207) 441-6624
Thepleasantoak, Inc
49 Oak St
Augusta
ME 04330-5118

Ph: (207) 441-6624

NPI Details:

NPI Number1275923369
Provider Enumeration Date01/28/2015
Last Update Date01/28/2015

Medicare PECOS Information:

Medicare PECOS PAC ID1456679521
Medicare Enrollment IDO20150422000076

News Archive

Hormone therapy can extend life in ovarian cancer patients

The study, published in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.

Study demonstrates effectiveness of combination therapy for breast cancer cells in vitro

A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro.

Compounds isolated from rattlesnake's venom show promise to fight against hepatitis C

A group of Brazilian scientists achieved promising results using isolated compounds from the venom of the South American rattlesnake in combat of hepatitis C.

Cardiologists question FDA recommendations on genetic testing before taking Plavix

Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration's recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Thepleasantoak, Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275923369NPI-NPPES
ME1038OtherMEME1038 PCAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical LC7597 (Maine)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Thepleasantoak, Inc acts as a billing entity for following providers:
Provider NameSusan A Brochu
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1144311135
PECOS PAC ID: 5395700942
Enrollment ID: I20041123000826

News Archive

Hormone therapy can extend life in ovarian cancer patients

The study, published in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.

Study demonstrates effectiveness of combination therapy for breast cancer cells in vitro

A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro.

Compounds isolated from rattlesnake's venom show promise to fight against hepatitis C

A group of Brazilian scientists achieved promising results using isolated compounds from the venom of the South American rattlesnake in combat of hepatitis C.

Cardiologists question FDA recommendations on genetic testing before taking Plavix

Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration's recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).

Read more Medical News

› Verified 7 days ago

News Archive

Hormone therapy can extend life in ovarian cancer patients

The study, published in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

Apitope-led consortium awarded FP7 Health Innovation funding to develop Graves' disease vaccine

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.

Study demonstrates effectiveness of combination therapy for breast cancer cells in vitro

A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro.

Compounds isolated from rattlesnake's venom show promise to fight against hepatitis C

A group of Brazilian scientists achieved promising results using isolated compounds from the venom of the South American rattlesnake in combat of hepatitis C.

Cardiologists question FDA recommendations on genetic testing before taking Plavix

Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration's recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).

Read more News

› Verified 7 days ago

Social Worker in Augusta, ME

Esm, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 776 Riverside Dr, Augusta, ME 04330
Phone: 207-622-5946    Fax: 207-622-4667
Augusta Neurology Pa
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 55 Middle Street, Suite 1, Augusta, ME 04330
Phone: 207-626-5445    Fax: 207-626-5446
Green Zone Counseling
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6 Baldwin St, Augusta, ME 04330
Phone: 207-592-6911    
Maine Behavioral Health Organization
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 49 Oak St, Augusta, ME 04330
Phone: 207-458-4642    
Suzanne White, Lcsw Corp
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 49 Oak St, Augusta, ME 04330
Phone: 207-649-4047    Fax: 207-622-6290
Graham Behavioral Services, Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 76 Eastern Ave, Augusta, ME 04330
Phone: 207-626-0003    Fax: 207-626-0004

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.